Epic's Cosmos dominates healthcare data

Diving deeper into

Epic

Company Report
Epic's Cosmos database, containing 5.7 billion patient encounters, positions them to become the dominant player in healthcare data analytics and research.
Analyzed 6 sources

Cosmos matters because Epic is turning control of the clinical workflow into control of one of healthcare's largest real world datasets. Epic already sits inside the daily work of nearly 2,000 hospitals in the Cosmos community, and that lets it combine longitudinal records, specialty data, and trial workflows in one system. That is a much stronger position than a standalone data vendor that has to buy, license, or stitch records together after the fact.

  • The advantage is not just size, it is data shape. Cosmos links inpatient and outpatient charts across systems and includes items like oncology details, vitals, patient generated data, birth records, and social drivers. That makes it useful for finding specific cohorts, measuring outcomes, and producing publishable research, not just broad claims style analysis.
  • Epic is also wiring that dataset into the commercial workflow. Its life sciences products let health systems check study feasibility, recruit participants through MyChart, collect consents, and run trial operations in Discovery. In practice, that means pharma can reach sites and patients through the same software hospitals already use for care delivery.
  • The main comparable is not another analytics startup, it is the EHR layer itself. Traditional interoperability vendors help apps pull records, but they usually sit outside the source system. Epic starts at the source, where clinicians document care, hospitals manage operations, and patients use MyChart, which gives it a cleaner path to scale data products and research services.

The next step is a shift from selling software to hospitals, toward taking a share of research, trial, and evidence generation budgets. As Cosmos keeps growing, Epic can become the default place where health systems, researchers, and life sciences companies match patients to studies, test hypotheses, and feed results back into care.